| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.5 |